Laboratorio Farmaceutico Erfo S.p.A. (BIT:ERFO)
Italy · Delayed Price · Currency is EUR 1.055
-0.025 (-2.31%)
At close: Oct 16, 2026
BIT:ERFO Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 9 | 13 | 11 | 12 | 18 | - | |
Market Cap Growth | -37.65% | 16.03% | -8.40% | -35.47% | - | - |
Enterprise Value | 9 | 13 | 10 | 11 | 16 | - |
Last Close Price | 1.05 | 1.47 | 1.26 | 1.24 | 1.92 | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 11.97 | 17.00 | 30.61 | 19.97 | 25.51 | - |
Forward PE | - | 12.78 | 19.46 | 13.10 | 12.30 | - |
PS Ratio | 0.92 | 1.29 | 1.79 | 1.99 | 3.87 | - |
PB Ratio | 1.04 | 1.50 | 1.43 | 1.50 | 2.33 | - |
P/TBV Ratio | 2.89 | 4.73 | 2.56 | 2.52 | 3.29 | - |
P/FCF Ratio | 7.57 | 14.74 | 9.20 | 11.99 | 60.57 | - |
P/OCF Ratio | 7.15 | 13.64 | 8.70 | 9.09 | 23.98 | - |
PEG Ratio | - | 0.27 | 2.03 | 0.54 | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.96 | 1.35 | 1.61 | 1.79 | 3.35 | - |
EV/EBITDA Ratio | 5.31 | 7.19 | 8.00 | 6.81 | 9.82 | - |
EV/EBIT Ratio | 8.64 | 12.36 | 18.50 | 12.66 | 16.00 | - |
EV/FCF Ratio | 7.97 | 15.50 | 8.25 | 10.77 | 52.37 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.14 | 0.16 | 0.05 | 0.06 | 0.07 | 0.16 |
Debt / EBITDA Ratio | 0.65 | 0.74 | 0.32 | 0.30 | 0.36 | 0.37 |
Debt / FCF Ratio | 0.98 | 1.59 | 0.33 | 0.47 | 1.93 | 0.35 |
Net Debt / Equity Ratio | 0.01 | 0.04 | 0.00 | -0.05 | -0.11 | 0.08 |
Net Debt / EBITDA Ratio | 0.03 | 0.16 | 0.01 | -0.24 | -0.55 | 0.18 |
Net Debt / FCF Ratio | 0.05 | 0.35 | 0.01 | -0.38 | -2.95 | 0.18 |
Asset Turnover | 0.81 | 0.90 | 0.61 | 0.57 | 0.53 | 0.69 |
Inventory Turnover | 4.48 | 4.90 | 3.49 | 3.44 | 2.86 | 3.50 |
Quick Ratio | 1.25 | 1.30 | 1.03 | 1.82 | 2.14 | 0.69 |
Current Ratio | 1.88 | 2.00 | 1.91 | 2.75 | 2.85 | 1.09 |
Return on Equity (ROE) | 8.65% | 9.25% | 4.57% | 7.51% | 11.39% | 22.30% |
Return on Assets (ROA) | 5.61% | 6.13% | 3.30% | 5.06% | 6.98% | 13.61% |
Return on Invested Capital (ROIC) | 8.91% | 9.28% | 4.66% | 8.39% | 12.36% | 22.12% |
Return on Capital Employed (ROCE) | 11.00% | 10.70% | 6.20% | 9.30% | 10.80% | 28.90% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 8.36% | 5.88% | 3.27% | 5.01% | 3.92% | - |
FCF Yield | 13.21% | 6.78% | 10.87% | 8.34% | 1.65% | - |
Dividend Yield | 5.69% | - | - | 4.38% | - | - |
Payout Ratio | 19.59% | - | 157.01% | 28.11% | 77.96% | 184.40% |
Buyback Yield / Dilution | 0.13% | 0.68% | 0.26% | 4.44% | -500.00% | - |
Total Shareholder Return | 5.82% | 0.68% | 0.26% | 8.82% | -500.00% | - |